PortfoliosLab logoPortfoliosLab logo
CAN vs. WVE
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

CAN vs. WVE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Canaan Inc. (CAN) and Wave Life Sciences Ltd. (WVE). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, CAN achieves a -48.65% return, which is significantly higher than WVE's -66.47% return.


CAN

1D
-1.06%
1M
-30.46%
YTD
-48.65%
6M
-62.18%
1Y
-40.84%
3Y*
-44.92%
5Y*
-48.54%
10Y*

WVE

1D
-0.52%
1M
-20.61%
YTD
-66.47%
6M
-69.22%
1Y
-21.05%
3Y*
11.70%
5Y*
-4.83%
10Y*
-9.83%
*Multi-year figures are annualized to reflect compound growth (CAGR)

CAN vs. WVE - Yearly Performance Comparison


2026 (YTD)2025202420232022202120202019
CAN
Canaan Inc.
-48.65%-66.34%-11.26%12.14%-60.00%-13.15%-2.79%-32.22%
WVE
Wave Life Sciences Ltd.
-66.47%37.43%144.95%-27.86%122.93%-60.10%-1.81%-73.61%

Correlation

The correlation between CAN and WVE is 0.29, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.29

Correlation (3Y)
Calculated over the trailing 3-year period

0.25

Correlation (5Y)
Calculated over the trailing 5-year period

0.24

Correlation (All Time)
Calculated using the full available price history since Nov 21, 2019

0.20

Fundamentals

Market Cap

CAN:

$244.97M

WVE:

$1.14B

EPS

CAN:

-$0.38

WVE:

-$1.03

PS Ratio

CAN:

0.39

WVE:

14.13

PB Ratio

CAN:

0.64

WVE:

2.23

Total Revenue (TTM)

CAN:

$510.04M

WVE:

$71.80M

Gross Profit (TTM)

CAN:

$17.56M

WVE:

$29.09M

EBITDA (TTM)

CAN:

-$144.51M

WVE:

-$184.40M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

CAN vs. WVE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CAN
CAN Risk / Return Rank: 3131
Overall Rank
CAN Sharpe Ratio Rank: 2828
Sharpe Ratio Rank
CAN Sortino Ratio Rank: 3737
Sortino Ratio Rank
CAN Omega Ratio Rank: 3535
Omega Ratio Rank
CAN Calmar Ratio Rank: 2525
Calmar Ratio Rank
CAN Martin Ratio Rank: 2828
Martin Ratio Rank

WVE
WVE Risk / Return Rank: 4444
Overall Rank
WVE Sharpe Ratio Rank: 3737
Sharpe Ratio Rank
WVE Sortino Ratio Rank: 5757
Sortino Ratio Rank
WVE Omega Ratio Rank: 6262
Omega Ratio Rank
WVE Calmar Ratio Rank: 3333
Calmar Ratio Rank
WVE Martin Ratio Rank: 3232
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CAN vs. WVE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Canaan Inc. (CAN) and Wave Life Sciences Ltd. (WVE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


CANWVEDifference
Sharpe ratioReturn per unit of total volatility

-0.22

Sortino ratioReturn per unit of downside risk

-0.86

Omega ratioGain probability vs. loss probability

1.02

1.17

-0.15

Calmar ratioReturn relative to maximum drawdown

-0.50

-0.29

-0.21

Martin ratioReturn relative to average drawdown

-0.75

-0.55

-0.20

CAN vs. WVE - Sharpe Ratio Comparison

The current CAN Sharpe Ratio is -0.34, which is lower than the WVE Sharpe Ratio of -0.13. The chart below compares the historical Sharpe Ratios of CAN and WVE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


CANWVEDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.34

-0.13

-0.22

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.44

-0.04

-0.39

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

-0.10

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.31

-0.09

-0.21

Drawdowns

CAN vs. WVE - Drawdown Comparison

The maximum CAN drawdown since its inception was -99.03%, roughly equal to the maximum WVE drawdown of -97.77%. Use the drawdown chart below to compare losses from any high point for CAN and WVE.


Loading charts...

Drawdown Indicators


CANWVEDifference

Max Drawdown

Largest peak-to-trough decline

-99.03%

-97.77%

-1.26%

Max Drawdown (1Y)

Largest decline over 1 year

-82.72%

-73.30%

-9.42%

Max Drawdown (3Y)

Largest decline over 3 years

-88.89%

-73.30%

-15.59%

Max Drawdown (5Y)

Largest decline over 5 years

-96.69%

-83.53%

-13.16%

Max Drawdown (10Y)

Largest decline over 10 years

-97.77%

Current Drawdown

Current decline from peak

-99.03%

-89.67%

-9.36%

Average Drawdown

Average peak-to-trough decline

-83.78%

-64.78%

-19.00%

Ulcer Index

Depth and duration of drawdowns from previous peaks

54.77%

38.35%

+16.42%

Volatility

CAN vs. WVE - Volatility Comparison

Canaan Inc. (CAN) has a higher volatility of 21.07% compared to Wave Life Sciences Ltd. (WVE) at 16.60%. This indicates that CAN's price experiences larger fluctuations and is considered to be riskier than WVE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


CANWVEDifference

Volatility (1M)

Calculated over the trailing 1-month period

21.07%

16.60%

+4.47%

Volatility (6M)

Calculated over the trailing 6-month period

60.03%

123.11%

-63.08%

Volatility (1Y)

Calculated over the trailing 1-year period

120.30%

169.12%

-48.82%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

111.48%

114.62%

-3.14%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

126.47%

99.03%

+27.44%

Dividends

CAN vs. WVE - Dividend Comparison

Neither CAN nor WVE has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

CAN vs. WVE - Financials Comparison

This section allows you to compare key financial metrics between Canaan Inc. and Wave Life Sciences Ltd.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00100.00M200.00M300.00M20222023202420252026
62.88M
38.25M
(CAN) Total Revenue
(WVE) Total Revenue
Values in USD except per share items

Frequently Asked Questions


CAN and WVE have a correlation of 0.29, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

CAN has higher volatility (21.07%) compared to WVE (16.60%). In terms of maximum drawdown, CAN dropped -99.03% vs WVE's -97.77%.

WVE currently has the higher Sharpe Ratio (-0.13 vs -0.34), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for CAN and WVE

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer